McNamara To Lead GSK’s Standalone Consumer Healthcare Business
Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.
You may also be interested in...
GSK has secured strong retail experience for its new standalone Consumer Healthcare business with the appointment of ex-Tesco boss Sir Dave Lewis.
J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.
Acquiring HRA Pharma, Perrigo could take OTC switch lead, likely starting with HRA’s daily oral contraceptive before moving to numerous other potential candidates. Pharmas previously busy in switch have other priorities for their consumer health businesses.